증권 기록 · 과거 분기 (아카이브)
ALC
Alcon Inc. · Healthcare · Medical - Specialties
18추적 보유자
+1Δ 보유자
56.88M보유 주식 수
$4.25B보고 가치
+3신규 편입 포지션
−3청산
모멘텀 입력값 (비교 가능한 운용사):
보유자 폭 +5.9% ·
주식 흐름 +0.8% ·
순 신규 포지션 0.0%
— 산식
광범위한 매집 — 더 많은 보유자에 걸쳐 주식 수 증가
모든 소유권 수치: 추적 대상 13F 운용사 한정, 보통주 포지션, 보고 기간 Q3 2025
시계열 보유 현황
| 분기 | 보유자 | Δ | 주식 수 | 보고 가치 | 신규 | 청산 |
|---|---|---|---|---|---|---|
| Q2 2026 | 127 | 0 | 163.73M | $10.99B | +8 | −7 |
| Q1 2026 | 128 | -2 | 149.67M | $11.22B | +4 | −7 |
| Q4 2025 | 130 | +1 | 168.20M | $13.30B | +2 | — |
| Q3 2025 | 18 | +1 | 56.88M | $4.25B | +3 | −3 |
| Q2 2025 | 15 | -4 | 57.20M | $5.06B | — | −4 |
| Q1 2025 | 16 | +1 | 22.35M | $2.11B | +1 | — |
| Q4 2024 | 15 | +2 | 21.30M | $1.81B | +3 | −1 |
| Q3 2024 | 12 | 0 | 17.31M | $1.73B | +2 | −2 |
| Q2 2024 | 12 | — | 18.62M | $1.66B | — | — |
보유 현황 · Q3 2025
| # | 운용사 | 주식 수 | Δ 주식 수 | 가치 | 비중 | 보유 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (패시브) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (패시브) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (패시브) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (패시브) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (패시브) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | The Vanguard Group ✦ (패시브) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 10.26M | +46.9% | $764.14M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 10.26M | +46.9% | $764.14M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 5.36M | — | $399.48M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 3.05M | — | $227.19M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Goldman Sachs Group ✦ | 3.05M | — | $227.19M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Goldman Sachs Group ✦ | 3.05M | — | $227.19M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Goldman Sachs Group ✦ | 3.05M | — | $227.19M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 2.18M | — | $162.79M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | PRIMECAP Management ✦ | 1.34M | -0.8% | $100.21M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 61 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 62 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 63 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 64 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 65 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 66 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 67 | BlackRock ✦ (패시브) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 68 | Marshall Wace ✦ | 706.23K | +40.6% | $52.60M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 69 | Marshall Wace ✦ | 706.23K | +40.6% | $52.60M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 70 | Marshall Wace ✦ | 706.23K | +40.6% | $52.60M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 71 | Marshall Wace ✦ | 706.23K | +40.6% | $52.60M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 72 | Point72 Asset Management ✦ | 522.80K | 신규 | $38.95M | 0.1% | New | 1 | SEC ↗ |
| 73 | Citadel Advisors ✦ | 227.55K | 신규 | $16.95M | 0.0% | New | 1 | SEC ↗ |
| 74 | Citadel Advisors ✦ | 227.55K | 신규 | $16.95M | 0.0% | New | 1 | SEC ↗ |
| 75 | Arrowstreet Capital ✦ | 216.06K | +1119.0% | $16.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 76 | Millennium Management ✦ | 159.57K | 신규 | $11.89M | 0.0% | New | 1 | SEC ↗ |
| 77 | Wellington Management ✦ | 96.58K | -25.5% | $7.19M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 78 | Wellington Management ✦ | 96.58K | -25.5% | $7.19M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 79 | Two Sigma Investments ✦ | 65.98K | -52.9% | $4.92M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 80 | AQR Capital Management ✦ | 11.83K | +43.1% | $881,306 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 81 | AQR Capital Management ✦ | 11.83K | +43.1% | $881,306 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 82 | State Street Global Advisors ✦ (패시브) | 6.12K | 0.0% | $456,225 | 0.0% | Held | 4 | SEC ↗ |
| 83 | Fisher Asset Management ✦ | 5.88K | -11.8% | $438,278 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"해당 운용사 비중" = 해당 운용사의 신고된 13F 주식 가치 대비 포지션 비중 — 확신도 지표. ✦ = 선별 운용사.
신규 매수자
| Point72 Asset Management | $38.95M | 0.1% |
| Citadel Advisors | $16.95M | 0.0% |
| Citadel Advisors | $16.95M | 0.0% |
| Millennium Management | $11.89M | 0.0% |
청산됨
| Norges Bank | $1.00B | 이었음 0.1% |
| Adage Capital Partners | $3.44M | 이었음 0.0% |
| D. E. Shaw & Co. | $1.11M | 이었음 0.0% |
전체 시장 맥락: 전체 13F 공시 기관 기준 (SEC 구조화 데이터, Q1 2026): 2 보유 기관, 868.08K 주식, $64.02M 신고 기준. 이는 위의 추적 유니버스 수치와 다른 이전 기간으로, 두 수치는 절대 혼용되지 않습니다.
공동 보유 빈도 높음
이 증권의 추적 보유자들이 가장 많이 함께 보유하는 종목 — 기본적 관계가 아닌 공동 보유 건수 기준.
출처: 파싱된 13F 보통주 포지션 기반 보유 현황(추적 유니버스, 변동 비교 세트); 내부자 행은 Form 3/4/5에서; 지분은 Schedule 13D/13G에서 수집; 모든 공시는 SEC EDGAR 원문으로 연결됩니다.
보고 기간: Q3 2025 ·
방법론 ·
API를 통해 조회